TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014
TCL Archive Intarferon Results Promising, ACS Says, And commits Another $3.4 Million February 22, 1980